文献速递运动医学小儿骨科关节外科

外侧关节外手术增强对青少年前交叉韧带再断裂风险及Tegner活动量表结局的影响:一项最短随访2年的匹配对比研究

Impact of Lateral Extra-Articular Procedure Augmentation on Rerupture Risk and Tegner Activity Scale Outcomes in Adolescent Anterior Cruciate Ligament: A Matched Comparative Study With a Minimum 2-Year Follow-up.
PubMed 文献 · Am J Sports Med · 2024-02-09

该回顾性队列研究分析2012年10月至2020年6月数据,纳入年龄<18岁、行初次前交叉韧带重建且随访至少2年的青少年,按年龄、性别、Tegner活动量表和半月板损伤匹配为单纯重建组与重建+外侧关节外手术增强组。结果显示增强组再断裂率显著低于单纯重建组(2.5% vs 13.6%,P=0.002),5年无再断裂生存更优(P=0.001),末次随访Tegner评分更高(7.2 vs 6.3,P=0.0042)。

要点

  • 青少年前交叉韧带重建加外侧关节外手术增强组再断裂率为2.5%,单纯重建组为13.6%(P=0.002)。
  • 增强组5年无再断裂生存显著更优(P=0.001),Cox回归显示单纯重建组再断裂风险增加6倍(P=0.004)。
  • 末次随访增强组Tegner评分显著更高(7.2 vs 6.3,P=0.0042),IKDC、KOOS、Lysholm、ACL-RSI及重返运动率无显著差异。

核心结论

  • 在青少年中,前交叉韧带重建联合外侧关节外手术增强显著降低再断裂风险并促进更高的术后活动水平。

研究设计与样本

  • 回顾性分析前瞻性收集的2012年10月至2020年6月数据,纳入年龄<18岁行初次前交叉韧带重建且随访至少2年的患者。
  • 按年龄、性别、Tegner活动量表和半月板损伤匹配为单纯前交叉韧带重建组与重建+外侧关节外手术增强组。
  • 研究为队列研究,证据等级3级;注册号NCT02511158。

主要发现

  • 最终分析单纯重建组132例、增强组121例(初始每组147例)。
  • 两组平均年龄均为16.1岁(标准差分别为1.1年和1.0年),患者和损伤特征相似(P>.05),术前功能评分相当。
  • 单纯重建组术前ACL-RSI评分显著低于增强组(P=0.0044)。
  • 增强组移植肌腱断裂率2.5%,显著低于单纯重建组的13.6%(P=0.002);增强组归因风险降低11.1%,需治疗人数为9。
  • Kaplan-Meier分析显示增强组5年无再断裂生存显著更优(P=0.001);Cox回归证实单纯重建组再断裂风险增加6倍(P=0.004)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the well-established role of lateral extra-articular procedures (LEAPs) in reducing failure rates after anterior cruciate ligament (ACL) reconstruction (ACLR) in the adult population, similar in-depth research for the adolescent and pediatric population remains lacking. PURPOSE: To examine the effect of the LEAP augmentation on the rerupture rate after ACLR in patients aged <18 years. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: This was a retrospective analysis of prospectively collected data from October 2012 to June 2020, involving adolescents <18 years old undergoing primary ACLR with a minimum follow-up of 2 years. Two groups, matched for age, sex, Tegner activity scale, and presence of meniscal injury, were established: ACLR alone and ACLR+LEAP augmentation. The primary outcome measure was the rate of rerupture after ACLR. The secondary outcome measures were the rate of non-graft rupture related reoperation after ACLR; rate of return to sport (RTS) rate, timing, and level compared with preinjury status; and functional scores including the International Knee Documentation Committee (IKDC) score, Knee injury and Osteoarthritis Outcome Score (KOOS) (Pain, Symptoms, Activities of Daily Living, Sport and Recreation, and Quality of Life), Tegner activity scale score, ACL Return to Sport after Injury (ACL-RSI) score, and Lysholm score. RESULTS: After accounting for follow-up losses, we analyzed 132 patients who underwent ACLR alone and 121 patients who underwent ACLR+LEAP from the initial 147 per group. The mean age of the patients in both groups was 16.1 years (SD, 1.1 and 1.0 years, respectively), with similar patient and injury characteristics across both groups (P > .05). Both groups also showed comparable preoperative functional scores. A significantly lower preoperative ACL-RSI score was observed in the ACLR-alone group compared with the ACLR+LEAP group (P = .0044). Graft rupture was significantly less common in the ACLR+LEAP group (2.5%) than in the ACLR-alone group (13.6%) (P = .002). The attributable risk reduction for ACLR+LEAP was 11.1%, and the calculated number needed to treat was 9. Kaplan-Meier analysis showed significantly better rerupture-free survival at 5 years for the ACLR+LEAP group (P = .001). Cox regression confirmed a 6-fold increased rerupture risk in the ACLR-alone group (P = .004). At the final follow-up, despite similar IKDC, KOOS, Lysholm, and ACL-RSI values across both groups, the ACLR+LEAP group had a significantly higher Tegner score (7.2 vs 6.3; P = .0042). No significant differences were observed in RTS rates or sport level compared with preinjury states between the groups. CONCLUSION: ACLR+LEAP augmentation significantly reduced rerupture risk and facilitated higher postoperative activity levels in adolescents. REGISTRATION: NCT02511158 (ClinicalTrials.gov identifier).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Moussa MK, Lefèvre N, Valentin E, et al. Impact of Lateral Extra-Articular Procedure Augmentation on Rerupture Risk and Tegner Activity Scale Outcomes in Adolescent Anterior Cruciate Ligament: A Matched Comparative Study With a Minimum 2-Year Follow-up. Am J Sports Med. 2024. PMID: 38333967. doi:10.1177/03635465231223703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。